Cargando…
Protection is not always a good thing: The immune system’s impact on gene therapy
There are many clinical trials underway for the development of gene therapies, and some have resulted in gene therapy products being commercially approved already. Significant progress was made to develop safer and more effective strategies to deliver and regulate genetic products. An unsolved aspec...
Autores principales: | de Freitas, Martiela Vaz, Frâncio, Lariane, Haleva, Laura, Matte, Ursula da Silveira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Genética
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295005/ https://www.ncbi.nlm.nih.gov/pubmed/35852088 http://dx.doi.org/10.1590/1678-4685-GMB-2022-0046 |
Ejemplares similares
-
Sending out an SOS - the bacterial DNA damage response
por: Lima-Noronha, Marco A., et al.
Publicado: (2022) -
RNP-world: The ultimate essence of life is a ribonucleoprotein process
por: de Farias, Sávio Torres, et al.
Publicado: (2022) -
Pharmacogenetics of HIV therapy: State of the art in Latin American countries
por: Velozo, Camila de Almeida, et al.
Publicado: (2022) -
The use of adenoviral vectors in gene therapy and vaccine
approaches
por: Araújo, Natália Meneses, et al.
Publicado: (2022) -
New insights into Canis familiaris papillomaviruses
genetics and biology: Is the genetic characterization of CPV types and their
variants an important clinical issue?
por: Reis, Jordana Dantas Rodrigues, et al.
Publicado: (2022)